You may be right. I hope the trial results are not mediocre. There are many companies that offer stem cell treatments of a variety of medical conditions that have no positive benefit to patients. I really hope this is not another in this category. The FDA needs to regulate this space a lot better. I do hope this company has an efficacious treatment but it got harder and harder to believe them with the lack of transparency. I am on the sidelines now after losing 20K but learned my lesson :)
Ten. I agree with you but still stand by no RS. The CEO holds way too many street shares to do a RS. I agree on the rest. They will issue many things when the timing is right, not one second before, no matter how much we email. They treated Medistem the same way, and look how that turned out :)
I hope this busts to the moon tomorrow, but in the mean time I add when I can. Cellar prices. ;)
News 
Market Data 
Discover 
